IOVANCE Trademark

Trademark Overview

On Monday, June 5, 2017, a trademark application was filed for IOVANCE with the United States Patent and Trademark Office. The USPTO has given the IOVANCE trademark a serial number of 87476198. The federal status of this trademark filing is REGISTERED as of Tuesday, September 7, 2021. This trademark is owned by Lion Biotechnologies, Inc. The IOVANCE trademark is filed in the Chemical Products, Pharmaceutical Products, and Medical & Beauty Services & Agricultural Services categories with the following description:

medical services, namely, modifying cells for the treatment of cancer and other diseases and medical conditions; immunotherapy treatments; medical diagnostic and treatment services; providing information in the field of oncology and immunotherapy treatments; providing medical information, consultancy and advisory services

cells for cancer treatment research; chemical preparations for use in clinical research; biological tissues, namely, human cells for use in scientific and medical research

pharmaceuticals for the treatment of oncological disease and disorders; pharmaceutical preparations for use in immunotherapy for the treatment of oncological disease and disorders
iovance

General Information

Serial Number87476198
Word MarkIOVANCE
Filing DateMonday, June 5, 2017
Status700 - REGISTERED
Status DateTuesday, September 7, 2021
Registration Number6479209
Registration DateTuesday, September 7, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 9, 2018

Trademark Statements

Goods and Servicesmedical services, namely, modifying cells for the treatment of cancer and other diseases and medical conditions; immunotherapy treatments; medical diagnostic and treatment services; providing information in the field of oncology and immunotherapy treatments; providing medical information, consultancy and advisory services
Goods and Servicescells for cancer treatment research; chemical preparations for use in clinical research; biological tissues, namely, human cells for use in scientific and medical research
Goods and Servicespharmaceuticals for the treatment of oncological disease and disorders; pharmaceutical preparations for use in immunotherapy for the treatment of oncological disease and disorders

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, June 12, 2017
Primary Code001
First Use Anywhere DateWednesday, February 24, 2021
First Use In Commerce DateWednesday, February 24, 2021
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 12, 2017
Primary Code005
First Use Anywhere DateWednesday, February 24, 2021
First Use In Commerce DateWednesday, February 24, 2021
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, June 12, 2017
Primary Code044
First Use Anywhere DateWednesday, December 9, 2020
First Use In Commerce DateWednesday, December 9, 2020

Trademark Owner History

Party NameIOVANCE BIOTHERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSAN CARLOS, CA 94070
US
Party NameIOVANCE BIOTHERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSAN CARLOS, CA 94070
US
Party NameIOVANCE BIOTHERAPEUTICS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressSAN CARLOS, CA 94070
US
Party NameLion Biotechnologies, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Carlos, CA 94070
US

Trademark Events

Event DateEvent Description
Thursday, June 8, 2017NEW APPLICATION ENTERED
Monday, June 12, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 2, 2017ASSIGNED TO EXAMINER
Saturday, September 2, 2017NON-FINAL ACTION WRITTEN
Saturday, September 2, 2017NON-FINAL ACTION E-MAILED
Saturday, September 2, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 6, 2017TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, September 13, 2017ASSIGNED TO LIE
Friday, September 15, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 15, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 27, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, October 4, 2017NON-FINAL ACTION WRITTEN
Wednesday, October 4, 2017NON-FINAL ACTION E-MAILED
Wednesday, October 4, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 27, 2017EXAMINERS AMENDMENT -WRITTEN
Monday, November 27, 2017EXAMINERS AMENDMENT E-MAILED
Monday, November 27, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 28, 2017EXAMINER'S AMENDMENT ENTERED
Tuesday, November 28, 2017EXAMINERS AMENDMENT -WRITTEN
Tuesday, November 28, 2017EXAMINERS AMENDMENT E-MAILED
Tuesday, November 28, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 28, 2017EXAMINERS AMENDMENT -WRITTEN
Tuesday, November 28, 2017EXAMINERS AMENDMENT E-MAILED
Tuesday, November 28, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, November 29, 2017EXAMINER'S AMENDMENT ENTERED
Wednesday, November 29, 2017EXAMINER'S AMENDMENT ENTERED
Friday, December 1, 2017EXAMINERS AMENDMENT -WRITTEN
Friday, December 1, 2017EXAMINERS AMENDMENT E-MAILED
Friday, December 1, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, December 4, 2017EXAMINER'S AMENDMENT ENTERED
Monday, December 4, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 20, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 9, 2018PUBLISHED FOR OPPOSITION
Tuesday, January 9, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 6, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, September 5, 2018SOU TEAS EXTENSION RECEIVED
Wednesday, September 5, 2018SOU EXTENSION 1 FILED
Wednesday, September 5, 2018SOU EXTENSION 1 GRANTED
Friday, September 7, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 6, 2019SOU TEAS EXTENSION RECEIVED
Wednesday, March 6, 2019SOU EXTENSION 2 FILED
Wednesday, March 6, 2019SOU EXTENSION 2 GRANTED
Friday, March 8, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 5, 2019SOU TEAS EXTENSION RECEIVED
Thursday, September 5, 2019SOU EXTENSION 3 FILED
Thursday, September 5, 2019SOU EXTENSION 3 GRANTED
Saturday, September 7, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 5, 2020SOU TEAS EXTENSION RECEIVED
Thursday, March 5, 2020SOU EXTENSION 4 FILED
Thursday, March 5, 2020SOU EXTENSION 4 GRANTED
Saturday, March 7, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 4, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, September 15, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 4, 2020SOU EXTENSION 5 FILED
Tuesday, September 15, 2020SOU EXTENSION 5 GRANTED
Wednesday, September 16, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 3, 2021TEAS STATEMENT OF USE RECEIVED
Wednesday, March 3, 2021USE AMENDMENT FILED
Saturday, March 6, 2021STATEMENT OF USE PROCESSING COMPLETE
Tuesday, July 20, 2021ASSIGNED TO EXAMINER
Wednesday, August 4, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, August 5, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 7, 2021REGISTERED-PRINCIPAL REGISTER
Wednesday, February 23, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, February 23, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 23, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 23, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 23, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 7, 2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 7, 2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 7, 2026TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

iovance treatment medical research cells immunotherapy services information namely treatments preparations